Fiscal Note
SB0087 - Preferred Drug List Revisions
State Impact:
Enactment of this bill will result in ongoing savings of $1,474,300 General Fund and $3,687,800 Federal Funds ($5,125,600 total). Additionally there are savings in FY 2009 of $122,900 General Fund and $307,300 Federal Funds ($430,200 total).
| Funding Source | FY 2009 Approp. | FY 2010 Approp. | FY 2011 Approp. | FY 2009 Revenue | FY 2010 Revenue | FY 2011 Revenue |
| General Fund | ($122,900) | ($1,474,300) | ($1,474,300) | $0 | $0 | $0 |
| Federal Funds | ($307,300) | ($3,687,800) | ($3,687,800) | $0 | $0 | $0 |
| Total | ($430,200) | ($5,162,100) | ($5,162,100) | $0 | $0 | $0 |
Individual, Business and/or Local Impact:
Enactment of this bill likely will not result in direct, measurable costs and/or benefits for individuals or local governments. The savings listed above come through lower drug reimbursements to pharmacies.
| 2/6/2009, 12:18:26 PM, Lead Analyst: Frandsen, R. | Office of the Legislative Fiscal Analyst |